Furthermore, this study strengthened the evidence of expression of TRPV1 in all leukemia types, emphasizing its modulation during the progression of the disease with higher levels of leukemic common progenitors during the chronic phase where additional epigenetic changes contribute to blastic transformation and TKI resistance. The gene discussed is TRPV1; the disease is leukemia.